Profile
Christina Cameron is currently Director-Investor Relations at Medicago, Inc. and Vice President-Investor Relations at Antibe Therapeutics, Inc. Former roles include Independent Director at Zero Candida Technologies, Inc. from 2024 to 2026, and Investor Relations & Media Contact at Medicenna Therapeutics Corp.
Education includes an undergraduate degree from Wilfrid Laurier University.
Christina Cameron active positions
| Companies | Position | Start |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Investor Relations Contact | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Investor Relations Contact | - |
Former positions of Christina Cameron
| Companies | Position | End |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Investor Relations Contact | - |
Training of Christina Cameron
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Wilfrid Laurier University
Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antibe Therapeutics, Inc.
Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Christina Cameron
















